UAS
TEVA icon

United Asset Strategies’s Teva Pharmaceuticals TEVA Stock Holding History

United Asset Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,350
Closed -$308K – 131
2014
Q4 		$308K Hold
5,350
– – 0.13% 99
2014
Q3 		$288K Hold
5,350
– – 0.13% 104
2014
Q2 		$280K Hold
5,350
– – 0.14% 102
2014
Q1 		$283K Buy
+5,350
New +$247K 0.16% 91

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

United Asset Strategies's TEVA Position: Q1 2015 in Review

United Asset Strategies sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 5,350 shares — an estimated $308K sold.

United Asset Strategies first reported a position in TEVA in Q1 2014 and held it in 4 quarters. The position peaked at $308K in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • United Asset Strategies reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • United Asset Strategies sold 5,350 Teva Pharmaceuticals shares in Q1 2015, an estimated $308K.
  • United Asset Strategies first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • United Asset Strategies's Teva Pharmaceuticals position peaked at $308K in Q4 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on United Asset Strategies's 13F filing for Q1 2015, filed 13 May 2015.